NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
PSNY
Polestar Automotive Holding UK PLC
There isn't enough reported data to score PSNY yet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
PSNY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Stable |
PSNY's balance sheet is currently stable, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | โ |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | โ |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
PSNY PE Valuation
PSNY has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
NKE has the edge over PSNY on the outlook, with more favorable earnings and profitability expectations.
PSNY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PSNY's losses to grow, with revenue declining.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
PSNY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | -$16.80 | -$9.90 |
PSNY and NKE do not have enough comparable growth data to identify a winner.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
PSNY has the stronger quarterly revenue trend. Revenue is down 4.3% for NKE versus up 16% for PSNY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
PSNY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $1.4B | +57% |
| Q4 2024 | $1.1B | -0.2% |
| Q2 2024 | $905.8M | -26% |
| Q4 2023 | $1.1B | -54% |
| Q4 2022 | $2.5B | +318% |
| Q4 2021 | $589.5M | +100% |
| Q3 2021 | $212.9M | -28% |
| Q2 2021 | $267.4M | +2573% |
PSNY's revenue is recovering but still below its 2022 peak: $1.4B last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -77% | -52 points |
| Q4 2024 | -120% | -101 points |
| Q2 2024 | -51% | +5.9 points |
| Q4 2023 | -86% | +52 points |
| Q2 2023 | -25% | -25 points |
| Q4 2022 | -18% | -18 points |
| Q4 2021 | -57% | -57 points |
| Q3 2021 | -138% | -98 points |
PSNY's operating margin was โ77% last quarter, down 52 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the stronger cash trend. Its trailing FCF is down 52% versus its history, compared with PSNY at down 120%.
PSNY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$585.7M | -$332.1M |
| Q4 2024 | -$885.6M | +$442.5M |
| Q2 2024 | -$253.5M | +$450.1M |
| Q4 2023 | -$1.3B | -$212.4M |
| Q4 2022 | -$1.1B | -$901.1M |
| Q4 2021 | -$214.6M | -1961% |
| Q3 2021 | -$55.5M | -581% |
| Q2 2021 | -$8.3M | +$56.5M |
PSNY has burned cash in almost every quarter: โ$3.1B over the past year, against โ$2.1B the year before.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
PSNY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 2.6x | Moderate |
PSNY's net debt is about 2.6 years of its operating earnings (EBITDA).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
PSNY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.9 | Oversold |
| Stochastic | 8.4 | Oversold |
PSNY's weekly RSI is 27 (oversold) and its Stochastic is 8 (oversold).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
PSNY PE vs Consumer Cyclical Sector
PSNY has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over PSNY on trend strength, trading above more of its moving averages.
PSNY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.83 | 12% below |
| 20 week MA | $10.0 | 57% below |
| 50 week MA | $15.2 | 72% below |
| 100 week MA | $22.9 | 81% below |
| 200 week MA | $47.9 | 91% below |
PSNY is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over PSNY on returns for 2026, with the stronger performance.
PSNY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $292.8 | $346.5 | +18% |
| 2022 | $346.5 | $146.4 | -58% |
| 2023 | $146.4 | $67.8 | -54% |
| 2024 | $67.8 | $33.3 | -51% |
| 2025 | $33.3 | $17.5 | -47% |
| 2026 YTD | $17.5 | $4.26 | -76% |
PSNY has finished four years in a row lower, and it's down 76% so far in 2026.